Talía Malagón1, Ann N Burchell2,3, Mariam El-Zein1, Julie Guénoun4,5, Pierre-Paul Tellier6, François Coutlée4,5, Eduardo L Franco1,7. 1. Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, Canada. 2. Department of Family and Community Medicine and Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto. 3. Department of Family and Community Medicine and Dalla Lana School of Public Health, University of Toronto, Canada. 4. Département de Microbiologie et Infectiologie, Centre Hospitalier de l'Université de Montréal. 5. Département de Microbiologie et Immunologie, Université de Montréal. 6. Department of Family Medicine, McGill University. 7. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Abstract
Background: Detection of human papillomavirus (HPV) DNA in genital samples may not always represent true infections but may be depositions from infected sexual partners. We examined whether sexual risk factors and a biomarker (Y chromosome DNA) were associated with genital HPV partner concordance and estimated the fraction of HPV detections potentially attributable to partner deposition. Methods: The HITCH study enrolled young women attending a university or college in Montréal, Canada, and their male partners, from 2005 to 2010. We tested baseline genital samples for Y chromosome DNA and HPV DNA using polymerase chain reaction. Results: Type-specific HPV concordance was 42.4% in partnerships where at least one partner was HPV DNA positive. Y chromosome DNA predicted type-specific HPV concordance in univariate analyses, but in multivariable models the independent predictors of concordance were days since last vaginal sex (26.5% higher concordance 0-1 vs 8-14 days after last vaginal sex) and condom use (22.6% higher concordance in never vs always users). We estimated that 14.1% (95% confidence interval [CI], 6.3-21.9%) of HPV DNA detections in genital samples were attributable to vaginal sex in the past week. Conclusions: A substantial proportion of HPV DNA detections may be depositions due to recent unprotected vaginal sex.
Background: Detection of human papillomavirus (HPV) DNA in genital samples may not always represent true infections but may be depositions from infected sexual partners. We examined whether sexual risk factors and a biomarker (Y chromosome DNA) were associated with genital HPV partner concordance and estimated the fraction of HPV detections potentially attributable to partner deposition. Methods: The HITCH study enrolled young women attending a university or college in Montréal, Canada, and their male partners, from 2005 to 2010. We tested baseline genital samples for Y chromosome DNA and HPV DNA using polymerase chain reaction. Results: Type-specific HPV concordance was 42.4% in partnerships where at least one partner was HPV DNA positive. Y chromosome DNA predicted type-specific HPV concordance in univariate analyses, but in multivariable models the independent predictors of concordance were days since last vaginal sex (26.5% higher concordance 0-1 vs 8-14 days after last vaginal sex) and condom use (22.6% higher concordance in never vs always users). We estimated that 14.1% (95% confidence interval [CI], 6.3-21.9%) of HPV DNA detections in genital samples were attributable to vaginal sex in the past week. Conclusions: A substantial proportion of HPV DNA detections may be depositions due to recent unprotected vaginal sex.
Authors: Rebecca M Brotman; Johan H Melendez; Tukisa D Smith; Noya Galai; Jonathan M Zenilman Journal: Sex Transm Dis Date: 2010-01 Impact factor: 2.830
Authors: Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco Journal: J Infect Dis Date: 2008-05-15 Impact factor: 5.226
Authors: Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: Pascal van der Weele; Martijn Breeuwsma; Robine Donken; Elske van Logchem; Naomi van Marm-Wattimena; Hester de Melker; Chris J L M Meijer; Audrey J King Journal: PLoS One Date: 2019-03-04 Impact factor: 3.240
Authors: Harris Onywera; Anna-Lise Williamson; Luca Cozzuto; Sarah Bonnin; Zizipho Z A Mbulawa; David Coetzee; Julia Ponomarenko; Tracy L Meiring Journal: BMC Microbiol Date: 2020-04-06 Impact factor: 3.605